Showing results (271-280 of 413) with videos related to

Sort By:
Pageof 42
Neuroimage. Clinical|September 2, 2017
Diffusion tensor image segmentation of the cerebrum provides a single measure of cerebral small vessel disease severity related to cognitive changeOwen A Williams, Eva A Zeestraten, Philip Benjamin, et al.
Circulation|September 14, 2013
Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysisKa Sing Lawrence Wong, Yilong Wang, Xinyi Leng, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 12, 2020
In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer's diseaseAudrey Low, Elijah Mak, Maura Malpetti, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 22, 2018
Correction: The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1-6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7-34 pathogenic variantJulie W Rutten, Bastian J Van Eijsden, Marco Duering, et al.
The Lancet. Neurology|September 1, 2009
Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trialJörg Ederle, Leo H Bonati, Joanna Dobson, et al.
European Stroke Journal|September 9, 2022
MINocyclinE to Reduce inflammation and blood brain barrier leakage in small Vessel diseAse (MINERVA) trial study protocolRobin B Brown, Daniel J Tozer, Laurence Loubière, et al.
Neurology|November 14, 2019
How common are single gene mutations as a cause for lacunar stroke? A targeted gene panel studyRhea Y Y Tan, Matthew Traylor, Karyn Megy, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 17, 2015
Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388), Kailash Krishnan, Maia Beridze, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 23, 2018
The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1-6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7-34 pathogenic variantJulie W Rutten, Bastian J Van Eijsden, Marco Duering, et al.
The Lancet. Neurology|July 13, 2010
Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trialThompson G Robinson, John F Potter, Gary A Ford, et al.
Pageof 42